Answers are grounded in this paper and cite their sources.
The non-canonical inflammasome is a cytosolic innate immune complex that plays a central role in the recognition of lipopolysaccharide (LPS) from Gram-negative bacteria. Mediated by Caspase-11 in mice and Caspase-4 and Caspase-5 in humans, this pathway triggers IL-1β and IL-18 secretion as well as Gasdermin D-mediated pyroptosis. Cleaved Gasdermin D forms membrane pores that facilitate cytokine release and promote clearance of infected cells. Over the past decade, emerging findings have revealed that this pathway is far more intricate than initially appreciated. In this viewpoint, we reassess discoveries that have reshaped our understanding of immunity against Gram-negative bacteria. Species-specific differences in LPS recognition, guanylate binding protein (GBP) involvement, and downstream effector activation are examined. We highlight key questions regarding the divergent roles of Caspase-4 and Caspase-5 in this pathway. In addition, we discuss immune escape strategies that hijack the non-canonical inflammasome. Inflammasome-independent functions extending beyond bacterial recognition are considered, and their broader implications are evaluated. Overall, this viewpoint revisits the classical inflammasome framework and reframes the non-canonical pathway as a complex, dynamic, and context-dependent signaling system.
No takes yet. Share an insight, caveat, or question.
Çelik et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: